chr7-124032342-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001136002.2(TMEM229A):c.662G>T(p.Arg221Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,542,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136002.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM229A | NM_001136002.2 | c.662G>T | p.Arg221Leu | missense_variant | 1/1 | ENST00000455783.3 | NP_001129474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM229A | ENST00000455783.3 | c.662G>T | p.Arg221Leu | missense_variant | 1/1 | 6 | NM_001136002.2 | ENSP00000395244.1 | ||
ENSG00000242593 | ENST00000484322.5 | n.75+63C>A | intron_variant | 1 | ||||||
ENSG00000242593 | ENST00000660727.1 | n.128+63C>A | intron_variant | |||||||
ENSG00000242593 | ENST00000667657.1 | n.154+63C>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 14AN: 135186Hom.: 0 AF XY: 0.0000955 AC XY: 7AN XY: 73282
GnomAD4 exome AF: 0.000175 AC: 243AN: 1389996Hom.: 0 Cov.: 30 AF XY: 0.000155 AC XY: 106AN XY: 685192
GnomAD4 genome AF: 0.000144 AC: 22AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.662G>T (p.R221L) alteration is located in exon 1 (coding exon 1) of the TMEM229A gene. This alteration results from a G to T substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at